Khyati Niral Shah (Khyati N Shah)

Years Active: 2018-2020
Publications (10 Years): 4

University of the Pacific (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of the Pacific Aug 22 2009 - Nov 05 2014

United States

PHD :: Molecular Pharmacology

Instititute of Chemical Technology Aug 01 2004 - Sep 07 2006

India

MSC :: Drug Delivery Technology

C.U.Shah College of Pharmacy Aug 01 2000 - Jul 01 2004

India

BSC :: Pharmacy

Publications

Angel A Ku, Hsien-Ming Hu, Xin Zhao, Khyati Niral Shah, Sameera Kongara, Di Wu, Frank McCormick, Allan Balmain, Sourav Bandyopadhyay
Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility. Nature communications 11 (1) (2020)
Khyati Niral Shah, Sourav Bandyopadhyay
Targeting the evolution of drug resistance in lung cancer. Molecular & cellular oncology 6 (5) (2019)
Khyati Niral Shah, Roma Bhatt, Julia Rotow, Julia Rohrberg, Victor Olivas, Victoria E Wang, Golzar Hemmati, Maria M Martins, Ashley Maynard, Jonathan Kuhn, Jacqueline Galeas, Hayley J Donnella, Swati Kaushik, Angel Ku, Sophie Dumont, Gregor Krings, Henry J Haringsma, Liliane Robillard, Andrew D Simmons, Thomas C Harding, Frank McCormick, Andrei Goga, Collin M Blakely, Trever G Bivona, Sourav Bandyopadhyay
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nature medicine 25 (1) (2018)
Hayley J Donnella, James T Webber, Rebecca S Levin, Roman Camarda, Olga Momcilovic, Nora Bayani, Khyati Niral Shah, James E Korkola, Kevan M Shokat, Andrei Goga, John D Gordan, Sourav Bandyopadhyay
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nature chemical biology 14 (8) (2018)

Khyati Niral Shah.css-eqlu8i{font-size:small;padding-left:4px;} (Khyati N Shah)